Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice

Horvath,Lukas; Bächinger,David; Honegger,Tim; Bodmer,Daniel; Monge Naldi,Arianne

doi:10.3892/etm.2019.7687

Functional and morphological analysis of different aminoglycoside treatment regimens inducing hearing loss in mice

Authors:
- Lukas Horvath
- David Bächinger
- Tim Honegger
- Daniel Bodmer
- Arianne Monge Naldi
View Affiliations

Affiliations: Department of Otorhinolaryngology, Head and Neck Surgery, University of Zurich, University Hospital Zurich, 8091 Zurich, Switzerland, Department of Biomedicine and The Clinic for Otorhinolaryngology, University Hospital Basel, 4031 Basel, Switzerland
Published online on: June 18, 2019 https://doi.org/10.3892/etm.2019.7687
Pages: 1123-1130
Copyright: © Horvath et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aminoglycoside ototoxicity is common in clinical practice but reliable protective agents currently do not exist. Aminoglycoside regimens causing ototoxicity in different laboratory animals are under investigation. The assessment method used most commonly to determine auditory effects is the auditory brainstem response (ABR). Distortion product otoacoustic emissions (DPOAE) have been used less frequently. A precise recommendation on the specific method to assess peripheral auditory function before and after aminoglycoside toxicity in mice does not exist. In order to evaluate various mouse models for ototoxic injury caused by various aminoglycoside regimens, there is a need for performing preliminary tests in small cohorts before large experiments. The aim of our study was to investigate different aminoglycoside regimens that cause substantial ototoxic damage in vivo. Aminoglycosides are safe and produce a detectable hearing threshold shift in a small cohort of mice that can be used as a model for preliminary tests. Different ototoxic regimens were assessed by ABR and DPOAE measurements pre‑ and post‑treatment. Further, the sensory cell loss was quantified by counting hair cells in the cochlea. It was revealed that an ototoxic regimen with kanamycin twice daily for 15 consecutive days is safe, well tolerated and produces an early significant hearing threshold shift detected by DPOAE in a small cohort of mice. The study compared ABR and DPOAE in mentioned regimens for the first time and illustrated that DPOAE is well suited for detecting hearing threshold shifts in high frequencies before ABR threshold shifts occur in accordance with predominating outer hair cell damage mainly in the basal turn of the cochlea.

View Figures

View References

1	World Health Organization, Geneva. WHO Fact sheet 2018. Deafness and hearing loss, . http://www.who.int/mediacentre/factsheets/fs300/en/March 20–2019
2	Brummett RE and Morrison RB: The incidence of aminoglycoside antibiotic-induced hearing loss. Arch Otolaryngol Head Neck Surg. 116:406–410. 1990. View Article : Google Scholar : PubMed/NCBI
3	Blakley BW, Hochman J, Wellman M, Gooi A and Hussain AE: Differences in ototoxicity across species. J otolaryngol Head Neck Surg. 37:700–703. 2008.PubMed/NCBI
4	Guthrie OW: Aminoglycoside induced ototoxicity. Toxicology. 249:91–96. 2008. View Article : Google Scholar : PubMed/NCBI
5	Murillo-Cuesta S, Contreras J, Cediel R and Varela-Nieto I: Comparison of different aminoglycoside antibiotic treatments to refine ototoxicity studies in adult mice. Lab Anim. 44:124–131. 2009. View Article : Google Scholar : PubMed/NCBI
6	Corrado AP, de Morais IP and Prado WA: Aminoglycoside antibiotics as a tool for the study of the biological role of calcium ions. Historical overview. Acta Physiol Pharmacol Latinoam. 39:419–430. 1989.PubMed/NCBI
7	Forge A and Schacht J: Aminoglycoside antibiotics. Audiol Neurootol. 5:3–22. 2000. View Article : Google Scholar : PubMed/NCBI
8	Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H and Striessnig J: Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35:14659–14664. 1996. View Article : Google Scholar : PubMed/NCBI
9	Poirrier AL, Van den Ackerveken P, Kim TS, Vandenbosch R, Nguyen L, Lefebvre PP and Malgrange B: Ototoxic drugs: Difference in sensitivity between mice and guinea pigs. Toxicol Lett. 193:41–49. 2010. View Article : Google Scholar : PubMed/NCBI
10	Walton K, Dorne JL and Renwick AG: Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans. Food Chem Toxicol. 42:261–274. 2004. View Article : Google Scholar : PubMed/NCBI
11	Yang B and Bankir L: Urea and urine concentrating ability: New insights from studies in mice. Am J Physiol Renal Physiol. 288:F881–F896. 2005. View Article : Google Scholar : PubMed/NCBI
12	Chen L, Xiong S, Liu Y and Shang X: Effect of different gentamicin dose on the plasticity of the ribbon synapses in cochlear inner hair cells of C57BL/6J mice. Mol Neurobiol. 46:487–494. 2012. View Article : Google Scholar : PubMed/NCBI
13	Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y and Schacht J: Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res. 158:165–178. 2001. View Article : Google Scholar : PubMed/NCBI
14	Steel KP and Bock GR: Hereditary inner-ear abnormalities in animals. Relationships with human abnormalities. Arch Otolaryngol. 109:22–29. 1983. View Article : Google Scholar : PubMed/NCBI
15	Probst FJ and Camper SA: The role of mouse mutants in the identification of human hereditary hearing loss genes. Hear Res. 130:1–6. 1999. View Article : Google Scholar : PubMed/NCBI
16	Hartman BH, Basak O, Nelson BR, Taylor V, Bermingham-McDonogh O and Reh TA: Hes5 expression in the postnatal and adult mouse inner ear and the drug-damaged cochlea. J Assoc Res Otolaryngol. 10:321–340. 2009. View Article : Google Scholar : PubMed/NCBI
17	Hirose K and Sato E: Comparative analysis of combination kanamycin-furosemide versus kanamycin alone in the mouse cochlea. Hear Res. 272:108–116. 2011. View Article : Google Scholar : PubMed/NCBI
18	Taylor RR, Nevill G and Forge A: Rapid hair cell loss: A mouse model for cochlear lesions. J Assoc Res Otolaryngol. 9:44–64. 2008. View Article : Google Scholar : PubMed/NCBI
19	West BA, Brummett RE and Himes DL: Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch Otolaryngol. 98:32–37. 1973. View Article : Google Scholar : PubMed/NCBI
20	Nourski KV, Miller CA, Hu N and Abbas PJ: Co-administration of kanamycin and ethacrynic acid as a deafening method for acute animal experiments. Hear Res. 187:131–133. 2004. View Article : Google Scholar : PubMed/NCBI
21	Russell NJ, Fox KE and Brummett RE: Ototoxic effects of the interaction between kanamycin and ethacrynic acid. Cochlear ultrastructure correlated with cochlear potentials and kanamycin levels. Acta Otolaryngol. 88:369–381. 1979. View Article : Google Scholar : PubMed/NCBI
22	Jansen TT, Bremer HG, Topsakal V, Hendriksen FG, Klis SF and Grolman W: Deafness induction in mice. Otol Neurotol. 34:1496–1502. 2013. View Article : Google Scholar : PubMed/NCBI
23	Oesterle EC and Campbell S: Supporting cell characteristics in long-deafened aged mouse ears. J Assoc Res Otolaryngol. 10:525–544. 2009. View Article : Google Scholar : PubMed/NCBI
24	Kendall A and Schacht J: Disparities in auditory physiology and pathology between C57BL/6J and C57BL/6N substrains. Hear Res. 318:18–22. 2014. View Article : Google Scholar : PubMed/NCBI
25	FELASA working group on revision of guidelines for health monitoring of rodents and rabbits, ; Mähler Convenor M, Berard M, Feinstein R, Gallagher A, Illgen-Wilcke B, Pritchett-Corning K and Raspa M: FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab Anim. 48:178–192. 2014. View Article : Google Scholar : PubMed/NCBI
26	Horvath L, Bodmer D, Radojevic V and Monge Naldi A: Activin signaling disruption in the cochlea does not influence hearing in adult mice. Audiol Neurootol. 20:51–61. 2015. View Article : Google Scholar : PubMed/NCBI
27	Mhatre AN, Li Y, Bhatia N, Wang KH, Atkin G and Lalwani AK: Generation and characterization of mice with Myh9 deficiency. Neuromolecular Med. 9:205–215. 2007. View Article : Google Scholar : PubMed/NCBI
28	Koay G, Heffner R and Heffner H: Behavioral audiograms of homozygous med(J) mutant mice with sodium channel deficiency and unaffected controls. Hear Res. 171:111–118. 2002. View Article : Google Scholar : PubMed/NCBI
29	Sedo-Cabezon L, Boadas-Vaello P, Soler-Martin C and Llorens J: Vestibular damage in chronic ototoxicity: A mini-review. Neurotoxicology. 43:21–27. 2014. View Article : Google Scholar : PubMed/NCBI
30	Versnel H, Agterberg MJ, de Groot JC, Smoorenburg GF and Klis SF: Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide. Hear Res. 231:1–12. 2007. View Article : Google Scholar : PubMed/NCBI
31	Liu H, Ding DL, Jiang HY, Wu XW, Salvi R and Sun H: Ototoxic destruction by co-administration of kanamycin and ethacrynic acid in rats. J Zhejiang Univ Sci B. 12:853–861. 2011. View Article : Google Scholar : PubMed/NCBI
32	Ding D, McFadden SL, Browne RW and Salvi RJ: Late dosing with ethacrynic acid can reduce gentamicin concentration in perilymph and protect cochlear hair cells. Hear Res. 185:90–96. 2003. View Article : Google Scholar : PubMed/NCBI
33	Ohtani I, Ohtsuki K, Omata T, Ouchi J and Saito T: Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside antibiotics. ORL J Otorhinolaryngol Relat Spec. 40:53–63. 1978. View Article : Google Scholar : PubMed/NCBI
34	Fausti SA, Rappaport BZ, Schechter MA, Frey RH, Ward TT and Brummett RE: Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: Selected case studies. Am J Otolaryngol. 5:177–182. 1984. View Article : Google Scholar : PubMed/NCBI
35	Tan CT, Hsu CJ, Lee SY, Liu SH and Lin-Shiau SY: Potentiation of noise-induced hearing loss by amikacin in guinea pigs. Hear Res. 161:72–80. 2001. View Article : Google Scholar : PubMed/NCBI
36	Aksoy F, Dogan R, Ozturan O, Eren SB, Veyseller B, Pektas A and Hüseyinbas Ö: Protective effect of trimetazidine on amikacin-induced ototoxicity in rats. Int J Pediatr Otorhinolaryngol. 78:663–669. 2014. View Article : Google Scholar : PubMed/NCBI
37	Aksoy F, Dogan R, Ozturan O, Yildirim YS, Veyseller B, Yenigun A and Ozturk B: Betahistine exacerbates amikacin ototoxicity. Ann Otol Rhinol Laryngol. 124:280–287. 2015. View Article : Google Scholar : PubMed/NCBI
38	Shi Y and Martin WH: ABR and DPOAE detection of cochlear damage by gentamicin. J Basic Clin Physiol Pharmacol. 8:141–155. 1997. View Article : Google Scholar : PubMed/NCBI
39	Kakigi A, Hirakawa H, Harel N, Mount RJ and Harrison RV: Comparison of distortion-product and transient evoked otoacoustic emissions with ABR threshold shift in chinchillas with ototoxic damage. Auris Nasus Larynx. 25:223–232. 1998. View Article : Google Scholar : PubMed/NCBI
40	Peguero B and Tempel BL: A chromosome 17 locus engenders frequency-specific non-progressive hearing loss that contributes to age-related hearing loss in mice. J Assoc Res Otolaryngol. 16:459–471. 2015. View Article : Google Scholar : PubMed/NCBI